文章摘要

MiR-146b通过靶向TRAF6减轻狼疮性肾炎肾小球系膜细胞的损伤

作者: 1林梅, 1宋丹, 1黄月桂
1 中国科学院大学深圳医院(光明)肾内科,广东 深圳 518000
通讯: 林梅 Email: mlqa17208@163.com
DOI: 10.3978/j.issn.2095-6959.2022.07.001
基金: 光明区经济发展专项资金(2020R01017)。

摘要

目的:研究微RNA-146b(microRNA-146b,miR-146b)对狼疮性肾炎小鼠肾小球系膜细胞增殖、炎症因子分泌以及细胞周期的影响及其潜在机制。方法:采用双荧光素酶报告基因实验验证miR-146b和肿瘤坏死因子受体相关因子6(tumor necrosis factor receptor-associated factor 6,TRAF6)的靶向关系;实时定量聚合酶链反应(qRT-PCR)和蛋白质印迹法检测TRAF6蛋白的表达水平;将肾小球系膜细胞分为miR-control组(转染miR-146b模拟物阴性对照)、miR-146b mimic组(转染miR-146b模拟物)、miR-146b mimic+NC组(共转染miR-146b模拟物和空载质粒pcDNA-NC)和miR-146b mimic+TRAF6组(共转染miR-146b模拟物和TRAF6过表达质粒);采用细胞计数试剂盒8(CCK-8)和免疫荧光染色法检测细胞增殖;酶联免疫吸附试验(ELISA)检测细胞培养上清液中炎症因子的水平;流式细胞术分析细胞周期。结果:MiR-146b靶向结合TRAF6并负调控TRAF6的表达。与miR-control组比较,miR-146b mimic组细胞的增殖能力显著减弱,细胞培养上清液中炎症因子白细胞介素1β(interleukin-1β,IL-1β)、白细胞介素6(interleukin-6,IL-6)和肿瘤坏死因子α(tumor necrosis factor-α,TNF-α)的水平降低,细胞发生G0/G1期阻滞;过表达TRAF6显著逆转了miR-146b对肾小球系膜细胞增殖和炎症因子分泌的抑制作用,减少G0/G1期细胞占比,促使细胞进入S期。结论:MiR-146b可能通过靶向TRAF6减轻狼疮性肾炎肾系膜细胞的炎性损伤。
关键词: 狼疮性肾炎;肾小球系膜细胞;微小RNA-146b;肿瘤坏死因子受体相关因子6

MiR-146b alleviates glomerular mesangial cell damage in lupus nephritis by targeting TRAF6

Authors: 1LIN Mei, 1SONG Dan, 1HUANG Yuegui
1 Department of Nephrology, University of Chinese Academy of Sciences, Shenzhen Hospital (Guangming), Shenzhen Guangdong 518000, China

CorrespondingAuthor: LIN Mei Email: mlqa17208@163.com

DOI: 10.3978/j.issn.2095-6959.2022.07.001

Foundation: This work was supported by the Special Fund for Economic Development in Guangming District, China (2020R01017).

Abstract

Objective: To investigate the effects of microRNA-146b (miR-146b) on the proliferation, secretion of inflammatory factors, and cell cycle of mesangial cells in mice with lupus nephritis and its potential mechanism. Methods: The targeting relationship between miR-146b and tumor necrosis factor receptor-associated factor 6 (TRAF6) was verified by dual luciferase reporter gene assay. Real-time quantitative polymerase chain reaction (qRT-PCR) and Western blotting were used to detect TRAF6 expression. The mesangial cells were divided into a miR-control group (negative control transfected with miR-146b mimic), a miR-146b mimic group (transfected with miR-146b mimic), a miR-146b mimic + NC group (co-transfected with miR-146b mimics and empty plasmid PCDNA-NC) and a miR-146b mimic + TRAF6 group (co-transfected with miR-146b mimics and TRAF6 overexpression plasmid). Cell counting kit 8 (CCK-8) and immunofluorescent staining were used to detect cell proliferation. The levels of inflammatory cytokines in supernatant were detected by enzyme-linked immunosorbent assay (ELISA). Cell cycle was analyzed by flow cytometry. Results: MiR-146b targeted and negatively regulated the expression of TRAF6. Compared with miR-control group, the proliferation ability of cells in miR-146b mimic group was significantly decreased, the levels of inflammatory factors interleukin 1β (IL-1β), interleukin 6 (IL-6) and tumor necrosis factor α (TNF-α) in cell supernatant were decreased, and the cells were arrested in G0/G1 phase. Overexpression of TRAF6 significantly reversed the inhibitory effect of miR-146b on the proliferation and secretory of inflammatory factors in mesangial cells, reduced the proportion of G0/G1 phase cells, and promoted the cells to enter into S phase. Conclusion: MiR-146b may alleviate the inflammatory damage of mesangial cells in lupus nephritis by targeting TRAF6.

Keywords: lupus nephritis; glomerular mesangial cell; microRNA-146b; tumor necrosis factor receptor-associated factor 6

文章选项